Effects of erythropoiesis-stimulating agents on overall survival of International Prognostic Scoring System Low/Intermediate-1 risk, transfusion-independent myelodysplastic syndrome patients: a cohort study.

ABSTRACT:

SUBMITTER: Messa E 

PROVIDER: S-EPMC6312022 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature